Sawaf Aziz: insider trades.
Sawaf Aziz reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Sawaf Aziz
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | Officer · SVP & CHIEF FINANCIAL OFFICER | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-23 | Theravance Biopharma, Inc. | D | 108,436 | — | 23,439 | Form 4 |
| 2026-09-23 | Theravance Biopharma, Inc. | D | 204,966 | — | 131,875 | Form 4 |
| 2026-09-23 | Theravance Biopharma, Inc. | D | 23,439 | — | 0 | Form 4 |
| 2026-08-20 | Theravance Biopharma, Inc. | F | 8,112 | $16.95 | 336,841 | Form 4 |
Questions
What stock did Sawaf Aziz buy or sell?
Sawaf Aziz reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is Sawaf Aziz the same person as other filers with this name?
This page covers SEC CIK 1961289 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/sawaf-aziz-1961289.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.